The percent increase associated with fixed K562-CD161 was almost identical to that observed for unfixed K562-CD161 (data not shown). Our previous study demonstrated that LLT1 stimulation with a monoclonal antibody fails to alter natural cytotoxicity [11]. We performed cytotoxicity assays to determine whether interaction of LLT1 with CD161 plays any functional role in NK cell activation. NK92 cells were used as effectors against 51Cr-labelled K562 target cells stably transfected with CD161 or empty pCI-neo vector. In some reactions, K562 target cells were blocked

with DX12 anti-CD161 monoclonal antibody. K562-CD161 target cells were not associated with altered levels of killing compared to K562-pCI-neo targets, and blocking CD161 was not associated with any altered levels of killing (Fig. 6). These results suggest that LLT1 activation by CD161 does not regulate selleck screening library NK cell cytotoxicity. Rapid production of IFN-γ is a critical role of NK cells responding to infection. LLT1 is a potent activator Selleckchem CH5424802 of IFN-γ production on human NK cells [10, 11]. To study the mechanisms of LLT1 signalling, we have developed a novel model of LLT1 ligation using NK92 and K562 cells stably transfected with the LLT1 natural ligand, CD161. Using LLT1:CD161 functional model, we have demonstrated that LLT1 stimulated IFN-γ

production is associated with the ERK signalling pathway and possibly the p38 pathway as well. Furthermore, IFN-γ secretion associated with LLT1 is detectable as little as six hours after ligation, and this IFN-γ production is not associated with

altered IFN-γ mRNA expression. We have demonstrated for the first time that LLT1 is expressed on the NK92 cell line, and that LLT1 is functional here in a manner identical to that observed on freshly isolated human NK cells and on the NK cell line YT. Our present data consistently demonstrated that LLT1 ligation on NK92 by its ligand CD161 strongly stimulates IFN-γ production. However, LLT1 ligation has never been associated with an increase or decrease in natural cytotoxicity [11]. These results illustrate the duality of NK activation Thalidomide pathways. Activating NK receptors are known to exhibit multiple functions. KIR2DL4 ligation stimulates IFN-γ production in resting NK cells and stimulates both IFN-γ and cytotoxicity in activated cells [8]. CD16 and 2B4 are capable of stimulating cytotoxicity in resting NK cells, but not IFN-γ production [25]. However, 2B4 is capable of stimulating cytotoxicity and IFN-γ production in the activated NK cell line YT [26]. Inhibition of either the p38 or ERK pathways abrogates 2B4-associated cytotoxicity, whereas only the p38 pathway is associated with 2B4-induced IFN-γ production [9, 27].